‘Give the American people a say in how AI develops’: OpenAI’s least favorite New York politico sees an opening

AI-regulation advocate Alex Bores launched Who Decides with $10 million raised and a target of $30 million before 2028 after losing a House primary that drew more than $40 million in outside spending. A super PAC partly funded by OpenAI president Greg Brockman and Andreessen Horowitz spent over $7.6 million against Bores, while Anthropic-backed Public First Action contributed $20 million in support. The group will work through organizations in 11 battleground states as federal AI legislation gains momentum, with advocates warning a Cruz-Klobuchar-Thune bill could preempt state AI laws despite 65% of Americans saying government has done too little to regulate AI.

Analysis

The investable implication is less about immediate compliance cost than about who can convert regulation into procurement credibility. PLTR is structurally better positioned than smaller AI application vendors if state-level testing, documentation, and incident-reporting norms proliferate: its government relationships, security posture, and existing deployment governance can turn compliance into a sales qualification rather than a margin drag. Over 6-18 months, a fragmented state regime would likely widen the moat around scaled enterprise vendors, while increasing customer preference for auditable, vertically integrated platforms.

Near-term, this is not a standalone PLTR catalyst; the company’s valuation remains far more sensitive to commercial growth, federal contract awards, and AI-platform conversion than to advocacy spending. The meaningful 1-3 month policy risk is federal legislation that preempts state rules while setting a low national standard: that would reduce the compliance advantage of incumbents and favor frontier-model providers and low-cost software competitors. Conversely, state adoption by Illinois or Massachusetts would make a de facto multi-state standard more likely and could pull forward enterprise governance spending.

PPHC is a possible second-order beneficiary only if AI policy becomes a sustained lobbying and coalition-building category rather than a one-cycle electoral issue. The relevant evidence is quarterly client-retention and AI-related public-affairs revenue disclosure, not political headlines; absent that disclosure, liquidity and small-cap execution risk outweigh conviction. Consensus may overstate AI regulation as uniformly negative for the sector: rules focused on documentation, safety testing, and reporting can consolidate demand toward trusted vendors without materially impairing enterprise AI adoption.

Key Decisions for Investors

• Maintain PLTR as a watch-list long rather than add solely on this development; add only if commercial-growth guidance holds and management identifies measurable governance/compliance-driven pipeline conversion. Thesis invalidation: decelerating U.S. commercial growth or evidence that customers defer deployments pending federal rules.
• For a 6-18 month relative-value expression, evaluate long PLTR versus a basket of unprofitable AI software names with limited regulated-industry exposure after confirmation that a second large state adopts frontier-AI requirements. Target is moat-driven relative outperformance, not absolute regulatory upside; stop if federal preemption materially displaces state standards.
• Set an event alert on federal AI legislation for explicit state-law preemption language. A strong federal floor with preemption is a relative negative for PLTR's compliance moat and should delay any regulation-based long add.
• Do not initiate PPHC from this news. Reassess after the next earnings release if management quantifies AI-policy mandates or client wins; any position should be small and liquidity-adjusted, with the thesis requiring recurring revenue rather than election-cycle spending.